Adults who develop amyotrophic lateral sclerosis (ALS) metabolize metals differently than those who do not develop the neurodegenerative disease, and this shows up in teeth during childhood, new research suggests.
News
Pregnancy and risk of multiple sclerosis
17/05/2020
To determine whether women with multiple sclerosis (MS) diagnosed according to current criteria are at an increased risk of postpartum relapses and to assess whether this risk is modified by breastfeeding or MS disease-modifying therapies (DMTs), the authors (Neurology. 2020 May 5;94(18):e1939-e1949) examined the electronic health records (EHRs) of...
Migraine and risk of stroke
17/05/2020
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a significant burden for those affected and a great economic cost for the society.
The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder (NMSD).
Benefits of yoga for migraine
17/05/2020
Adding yoga to a standard medication regimen is significantly better than medication alone in providing migraine relief, results of a randomized controlled trial show (Neurology. Published online May 6).
A recent study published in CNS drugs ( Chen MH, Goverover Y, Genova HM, DeLuca J) concludes that there is not enough evidence to support the use of drug treatments to improve the cognitive function of people with MS.
Anticoagulants and risk of bleeding
10/05/2020
MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation
Predictive MS risk factors
10/05/2020
A number of risk factors established for multiple sclerosis (MS) may also be valid for the process of evolution from a clinically isolated syndrome; these factors include low levels of vitamin D, smoking, and Epstein-Barr virus (EBV) infection. They interact with genetic risk factors, mainly Class II human leukocyte antigen (HLA) alleles. Some...
Statins: risk/benefit in stroke
10/05/2020
A new meta-analysis has concluded that the benefit of statin therapy in the prevention of ischemic stroke "greatly exceeds" the risk for intracerebral hemorrhage (ICH).
Albuminuria is a marker for endothelial dysfunction and knowledge on its association with stroke and stroke subtypes are limited.